李佩芳从"湿、痰、瘀"辨治三期代谢相关脂肪性肝病的临证经验OA
LI Peifang's Clinical Experience in Staging Syndrome Differentiation and Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease from"Dampness-Phlegm-Stasis"
代谢相关脂肪性肝病(MAFLD)是因肝细胞内甘油三酯及其他脂质病理性过度沉积所致的代谢性相关肝损伤,是全身代谢功能紊乱累及肝脏的表现.中医将其归属于"胁痛""积聚""肝癖"范畴,本病病机关键为湿、痰、瘀互结,三邪贯穿疾病始终,病位主要涉及肝、脾、肾三脏.李佩芳老师据此将本病分为早、中、晚三期,早期调肝脾,中期化痰瘀,晚期化浊毒兼以扶正,配合自拟方药及生活方式干预,可有效改善代谢紊乱,延缓疾病进展.
Metabolic dysfunction-associated fatty liver disease(MAFLD)is a metabolic dysfunction-related liver injury caused by pathological excessive deposition of triglycerides and other lipids in hepatocytes.As a manifestation of systemic metabolic dysfunction involving the liver,MAFLD is categorized under"hypochondriac pain","abdominal mass",and"liver indisposition"in traditional Chinese medicine(TCM).The key pathogenesis of this disease lies in the interminglement of dampness,phlegm,and blood stasis,with the three pathogens existing throughout the entire course of the disease.Additionally,the disease location mainly involves the liver,spleen,and kidney.Consequently,Professor LI Peifang divides the disease into early,middle,and late stages.The early-stage treatment focuses on regulating liver and spleen,the middle-stage on resolving phlegm and blood stasis,and the late-stage on eliminating toxin turbidity and reinforcing healthy Qi.With self-formulated decoctions and lifestyle interventions,disease progression can be effectively delayed by improving metabolic disorders.
龙瑞宁;李婧贤;李佩芳
山西中医药大学(山西 太原 030000)山西中医药大学(山西 太原 030000)山西中医药大学附属医院脾胃病科(山西 太原 030000)
代谢相关脂肪性肝病湿痰瘀脂毒病因病机辨证论治临证经验
metabolic dysfunction-associated fatty liver diseasedampness-phlegm-stasislipid toxicityetiology and pathogenesissyndrome differentiation and treatmentclinical experience
《基层中医药》 2026 (4)
30-34,5
山西中医药大学科技创新能力培育计划基础与临床合作研究专项(2024PY-JL-23-01)
评论